Aurora (ACB) exports first marijuana to the U.K.

: ACB | Aurora Cannabis Inc. Common Shares News, Ratings, and Charts

ACB – Aurora Cannabis Inc. said Monday that it had exported its first batch of cannabis oil to the United Kingdom.

Ahead of its quarterly earnings, Aurora Cannabis Inc. said Monday that it had exported its first batch of cannabis oil to the United Kingdom.

Aurora ACB, -6.59% ACB, -4.82%  stock fell 3% in Monday trading. It is set to report fiscal second-quarter earnings after the closing bell Monday. The company said that it was one of the first Canadian licensed pot producers to export product to the U.K., which allows specialist doctors to issue prescriptions for cannabis-based medicine.

Aside from Aurora, the largest Canadian licensed producers such as Canopy Growth Corp., Tilray Inc. and Cronos Group, have all told investors that they harbor ambitions to expand well beyond Canada’s borders into legal markets around the world. Canopy and Aurora have established a complex scheme that gives them the ability to acquire a majority stake in several U.S. companies that they once owned, should the federal government legalize marijuana.

The Toronto Stock Exchange said last year it would delist companies with assets in territories where marijuana is illegal — as it is federally in the U.S. — which prompted Canopy, Aurora and other to set up divest their U.S. holdings but retain the option to buy them back at a later date.

Pot stocks were largely lower Monday. Canopy CGC, -6.88% WEED, -6.01% stock fell 4%, Cronos CRON, +0.46% CRON, +0.96%  ticked up 0.6%, and TilrayTLRY, -3.60%  dropped 1.6%. The ETFMG Alternative Harvest ETF MJ, -2.56%which tracks a basket of pot stocks, fell 1.7%, and the Horizons Marijuana Life Sciences Index ETF HMMJ, -2.56%  fell 1.5%.

In a note to clients Sunday, Stifel analyst Christopher Growe wrote that Canadian licensed cannabis producers and U.S. multi-state operators have outperformed the market by a significant margin in 2019 so far. The Canadian companies are up 50%, the U.S.-based pot companies have gained 34%, as the S&P 500 index rose 8% SPX, -0.04% The Canadian companies have a combined market value of C$60 billion ($45 billion) and the largest eight American pot companies are valued by investors at $17 billion.

The Canadian Securities Exchange has emerged as a home for companies that have operations in the U.S. and wish to have a publicly traded stock. The CSE-listed TerrAscend Corp. said Monday that it plans to acquire the California pot retailer The Apothecarium for $118.4 million in cash and stock. The Apothecarium operates three stores in San Francisco and one in Las Vegas and TerrAscend said it would pay $73.7 million in cash and the rest in stock.

Elsewhere among U.S. stocks, Green Growth Brands Inc. GGBXF, -1.91% which has made a hostile takeover bid for Canadian weed company Aphria Inc., said that it had inked an all-stock deal with Simon Property Group Inc. SPG, +0.39%  to create a chain of cannabidiol, or CBD, stores. GGB said it was paying Simon Property $2.2 million in stock, and an additional $4.5 million in warrants.

Simon Property owns and operates malls across the U.S. and Green Growth said it expects to open the first store in Indianapolis in March. The Food and Drug Administration has said that at the moment, CBD is largely off-limits and that it is illegal to add to food or health products without FDA approval.

The FDA said Monday that it had sent warning letters to 12 companies and online advisory letters to five companies that are claiming their products prevent, treat or cure Alzheimer’s disease, among other diseases and health conditions.

According to Stifel’s Growe, U.S. licensed industry sales will grow to almost $10 billion, from the $6.9 billion his team estimates for 2018. Growe wrote that the estimates don’t include states such as New York, Illinois and New Jersey that will likely adopt adult-recreational cannabis use legislation in 2019. Including New York in 2020 and New Jersey in 2021, Growe wrote he expects sales in the U.S. of $17 billion.

Aurora Cannabis Inc. shares were trading at $7.12 per share on Monday afternoon, down $0.47 (-6.19%). Year-to-date, ACB has gained 43.55%, versus a 8.22% rise in the benchmark S&P 500 index during the same period.

ACB currently has a POWR Rating of C (Neutral), and is ranked #11 of 24 stocks in the Agriculture category.

This article is brought to you courtesy of MarketWatch.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Top Stories on

NYSE: AXP | American Express Company Common Stock News, Ratings, and Charts

Morgan Stanley upgrades American Express (AXP) to overweight

Analyst Betsy Graseck upgraded American Express to overweight from equal weight. Graseck also hiked her price target on the stock.
NYSE: MO | Altria Group, Inc. News, Ratings, and Charts

Altria Group Inc. (MO) reports earnings, stock moves lower

It’s no wonder Altria Group Inc. felt desperate for a piece of e-cigarette maker Juul Labs.
NASDAQ: TSLA | Tesla, Inc. News, Ratings, and Charts

Tesla (TSLA) reports Q1 earnings, shares trade lower

Notes: Tesla reported a loss of $702 million on an adjusted basis for the first three months of 2019.
NYSE: MMM | 3M Company Common Stock News, Ratings, and Charts

3M Co. (MMM) reports earnings, stock plummets

3M stock was suffering double-digit losses on Thursday. That’s unheard of.
: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

Should we expect more upside in pot stock Hexo (HEXO)?

HEXO's stock has been heating up, but there's more upside to come. Here's why.

Read More Stories

More Aurora Cannabis Inc. Common Shares (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News
Page generated in 1.1912 seconds.